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Background: At present there are no large scale nationally-representative studies from Sri Lanka on the prevalence
and associations of Diabetic Retinopathy (DR). The present study aims to evaluate the prevalence and risk factors
for DR in a community-based nationally-representative sample of adults with self-reported diabetes mellitus from
Sri Lanka.
Methods: A cross-sectional community-based national study among 5,000 adults (≥18 years) was conducted in
Sri Lanka, using a multi-stage stratified cluster sampling technique. An interviewer-administered questionnaire was
used to collect data. Ophthalmological evaluation of patients with ‘known’ diabetes (previously diagnosed at a
government hospital or by a registered medical practitioner) was done using indirect ophthalmoscopy. A binary-logistic
regression analysis was performed with ‘presence of DR’ as the dichotomous dependent variable and other
independent covariates.
Results: Crude prevalence of diabetes was 12.0% (n = 536), of which 344 were patients with ‘known’ diabetes.
Mean age was 56.4 ± 10.9 years and 37.3% were males. Prevalence of any degree of DR was 27.4% (Males-30.5%,
Females-25.6%; p = 0.41). In patients with DR, majority had NPDR (93.4%), while 5.3% had maculopathy. Patients with
DR had a significantly longer duration of diabetes than those without. In the binary-logistic regression analysis
in all adults duration of diabetes (OR:1.07), current smoking (OR:1.67) and peripheral neuropathy (OR:1.72)
all were significantly associated with DR.
Conclusions: Nearly 1/3rd of Sri Lankan adults with self-reported diabetes are having retinopathy. DR was
associated with diabetes duration, cigarette smoking and peripheral neuropathy. However, further prospective
follow up studies are required to establish causality for identified risk factors.
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Diabetes mellitus is currently the commonest endocrine
disorder, affecting nearly 6% of the world’s population
[1]. According to recent estimates by the International
Diabetes Federation, the number of patients with dia-
betes will increase by 55% to nearly 600 million by year
2035 [2]. The majority of the current 382 million people
with diabetes are aged between 40 and 59, and 80% of* Correspondence: pkatulanda@yahoo.com
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unless otherwise stated.them live in low- and middle-income countries like Sri
Lanka [2]. Diabetes is accompanied by a host of micro-
and macro-vascular complications, which further increases
the disease burden by causing premature death and loss of
productivity.
Diabetic Retinopathy (DR) is a common complication of
diabetes mellitus. It is one of the leading cause of blind-
ness worldwide, often affecting working-aged adults [3].
Globally the principal causes of visual impairment are un-
corrected refractive errors (43%) and cataracts (33%),
followed by glaucoma (2%), age related macular degener-
ation (1%) and diabetic retinopathy (1%) [4]. It is charac-
terized by signs of retinal ischemia and/or increasedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to neo-vascularization, hemorrhage, retinal detachment,
macular edema and/or retinal capillary non-perfusion [3].
Patients with DR are 25 times more likely to become blind
than those without diabetes [5]. Loss of productivity and
reduced quality of life in patients with DR leads to an
additional socioeconomic burden on the communities.
Common risk factors for the development of DR include
duration of diabetes, poor glycaemic control, elevated
blood pressure, presence of diabetic nephropathy and dys-
lipidaemia [5,6].
South Asia, commonly known as the Indian subcon-
tinent, is home to almost one-quarter of the world’s
population. Sri Lanka is a middle income South Asian
country with a population of about 21 million. Sri Lanka
is experiencing a significant epidemic of diabetes with a
rapid rise in prevalence over the last few decades [7].
Several recent studies from UK reported a higher preva-
lence of retinopathy in South Asians residing in UK than
in the native Europeans [8,9]. However the current evi-
dence regarding the epidemiology of DR amongst South
Asians is conflicting, with most studies based on South
Asians residing in European countries [8-11]. In the Sri
Lankan context a study by Fernando et al. in 1993 on
1,003 patients with type 2 diabetes attending a clinic,
showed that 31.3% had DR [12]. However, at present
there are no large scale community based nationally rep-
resentative studies from Sri Lanka evaluating prevalence
and associations of DR among the native adult popula-
tion. The present study aims to evaluate the prevalence
of DR and its risk factors from a large cohort of commu-
nity based South Asian adults with self-reported diabetes
mellitus derived from a nationally representative sample
from Sri Lanka.
Methods
Study population and sampling
A cross-sectional community based national study was
conducted in seven of the nine provinces in Sri Lanka
between August 2005 and September 2006 (Sri Lanka
Diabetes and Cardiovascular Study – SLDCS). Detailed
sampling is reported elsewhere [13]. In brief, five thou-
sand non-institutionalized adults over 18 years of age
were invited for the study using a multi-stage stratified
cluster sampling technique. One hundred clusters (of 50
adults each) were selected to represent the seven prov-
inces and clusters were divided amongst the provinces
using a probability-proportional to-size (PPS) technique
based on the total population of each province. In each
province the clusters were selected from the ‘Village
Office Units’ by a computer-generated random number
list. Voter registration lists of the selected ‘Village Officer
Units’ were used to randomly select the first household in
each cluster and a uniform criterion was used to select theremaining 49 households. Ethical approval for the study
was obtained from the Ethics Review Committee, Faculty
of Medicine, University of Colombo, Sri Lanka. Informed
written consent was obtained from all study participants
and the study was conduct in accordance with Declaration
of Helsinki.
Data collection
Data collection was carried out by a trained team of med-
ical undergraduates. An interviewer administered ques-
tionnaire was used to collect socio-demographic and
anthropometric details including age, gender, area of resi-
dence, ethnicity, level of education, household monthly in-
come (LKR – Sri Lankan Rupees), duration of diabetes,
height, weight, waist circumference and hip circumfer-
ence. Data on physical activity were collected using the
short version of the International Physical Activity Ques-
tionnaire. Height was measured using Harpenden stadi-
ometers (Chasmors Ltd, London, UK) to the nearest 0.1
cm, according to standard methods [14]. Body weight was
measured using a SALTER 920 digital weighing scale
(SALTER Ltd, Tonbridge, UK) to the nearest 0.1 kg. Body
Mass Index (BMI) was calculated as weight in kilograms
divided by height squared in meters (kg/m2). Waist cir-
cumference (WC) was measured midway between the iliac
crest and the lower rib margin at the end of normal expir-
ation and hip circumference was measured at the widest
level over the greater trochanters using a plastic flexible
tape to the nearest 0.1 cm. Waist to Hip Ratio (WHR) and
Waist to Height Ratio (WHtR) were calculated as waist
circumference divided by hip circumference and height
respectively [15]. Seated blood pressure was measured
after at least a 10-min rest with Omron IA2 digital blood
pressure monitors (Omron Healthcare, Singapore). Fast-
ing venous blood samples were obtained for glucose and
lipid estimation from all participants, details of analysis
have been previously described [13].
Definitions
Patients were considered to be a ‘known’ diabetic subject
if they had been previously diagnosed at a government
hospital or by a registered medical practitioner. New cases
(‘undiagnosed diabetes’) were diagnosed according to the
American Diabetes Association (ADA) and World Health
Organization (WHO) criteria diagnosis (Fasting blood
glucose >7.0 mmol/l (126 mg/dl) but not reporting them-
selves as having diabetes”) [16,17]. Hypertension was de-
fined as systolic blood pressure > 130 mmHg and/or
diastolic blood pressure > 85 mmHg and/or being on anti-
hypertensive treatment. Central obesity was classified as
WC> 90 cm for males and >80 cm for females (Asian cut-
offs). Obesity was defined as a BMI ≥ 27.5 kg/m2, based on
WHO criteria for Asians [18]. Urban and rural sectors
were defined according to the classification of the Sri
Table 1 Association of age, clinical and biochemical
parameters with diabetic retinopathy
Diabetic retinopathy p
value*Absent Present
Mean (±SD) Mean (±SD)
Age (years) 55.3 (±10.2) 55.8 (±12.3) 0.73
Duration of diabetes (years) 5.5 (±4.7) 7.9 (±6.8) 0.001
Height (cm) 155.4 (±9.7) 156.4 (±8.5) 0.44
Weight (kg) 58.6 (±11.8) 57.0 (±10.5) 0.29
Body Mass Index (kg/m2) 24.2 (±4.0) 23.2 (±3.2) 0.06
Waist circumference (cm) 86.5 (±10.4) 83.3 (±9.2) 0.02
Hip circumference (cm) 93.7 (±8.9) 92.0 (±7.9) 0.167
Waist to hip ratio 0.91 (±0.06) 0.92 (±0.06) 0.06
Waist to height ratio 0.56 (±0.07) 0.53 (±0.05) 0.006
Systolic blood pressure (mmHg) 138.2 (±20.8) 136.0 (±22.6) 0.44
Diastolic blood pressure (mmHg) 81.1 (±11.1) 77.4 (±12.8) 0.02
Fasting blood glucose (mg/dl) 136.7 (±55.1) 145.1 (±56.8) 0.27
Total cholesterol (mg/dl) 215.9 (±43.8) 223.9 (±46.5) 0.18
LDL cholesterol (mg/dl) 137.2 (±40.6) 145.9 (±40.8) 0.11
HDL cholesterol (mg/dl) 45.7 (±8.6) 48.2 (±9.7) 0.06
Triglycerides (mg/dl) 164.8 (±105.9) 148.7 (±60.8) 0.21
*patients with and without diabetes retinopathy.
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three categories (‘Inactive’, ‘Moderately active’ and ‘Highly
active’) based on the total MET minutes/week derived
from the IPAQ short version [19]. Peripheral neuropathy
was assessed using the validated Toronto Clinical Scoring
System (TCSS) (Score >5) [20].
Ophthalmological examination
Ophthalmological evaluation of all patients with ‘known’
diabetes was done, while the remaining new cases (‘un-
diagnosed diabetes’) were not evaluated due to logistic rea-
sons. All patients with ‘known’ diabetes had their pupils
dilated with 1% tropicamide and was screened for DR by
two Ophthalmologist by indirect ophthalmoscopy using slit
lamp biomicroscopy, who equally shared the screening
process and each patient was seen by only one ophthal-
mologist. Retinopathy was classified in to the following cat-
egories, according to the International Clinical DR Disease
Severity Scale; normal, Non Proliferative DR (NPDR) (mild/
moderate/severe), and proliferative DR, whilst presence/
absence of macular edema (maculopathy) was also noted
[21]. The presence of retinopathy in one eye was consid-
ered a diagnosis of DR and when asymmetrical DR was
present the stage of retinopathy was based on the affected
eye with the more severe grade of DR. Presence of Cata-
ract was assessed clinically during slit-lamp examination
using Lens Opacities Classification System (LOCS) III.
Statistical analysis
Data were analysed using SPSS v14 (SPSS Inc., Chicago,
IL, USA) statistical software package. The significance of
the differences between proportions and means was
tested using chi-square test and Student’s t-test/ANOVA
respectively. Multiple groups were compared with post-
hoc analysis using the fisher’s least significance difference
(LSD) test. Unless otherwise stated age- and sex-
standardized prevalence rates are presented throughout
the manuscript. In all statistical analyses p < 0.05 was con-
sidered significant. Data were analysed using SPSS v14
(SPSS Inc., Chicago, IL, USA) statistical software pack-
age. Subjects were divided in to two groups based on the
presence or absence of DR. A binary logistic regression
analysis was performed in all patients with ‘presence of
DR’ as the dichotomous dependent variable (0 = DR
absent; 1 = DR present) and duration of diabetes (con-
tinuous), current smoking (binary), central obesity (binary)
and peripheral neuropathy (binary) as the independent
variables. The explanatory independent variables that
were associated with the dependent variable in uni-
variate analysis (p < 0.25) were selected to be included
in the regression analysis. A similar binary logistic re-
gression analysis with above dependant and independent
variables was also performed separately for both males
and females.Results
Sample characteristics
Out of the 5000 invited subjects, 4485 participated in
the study (response rate 89.7%). The crude prevalence of
diabetes was 12.0% (n = 536), of which 344 (64.2%) were
patients with ‘known’ diabetes. This report is based on
312 subjects with ‘known’ diabetes after excluding 33
subjects with incomplete data. Mean age (±SD) was 56.4 ±
10.9 years and 37.3% (n = 116) were males. The mean
height (±SD), weight (±SD), BMI (±SD), waist circumfer-
ence (±SD) and hip circumference (±SD) was 155.5 ± 9.2
cm, 57.7 ± 11.4 kg, 23.8 ± 3.8 kg/m2, 85.4 ± 10.6 cm and
92.9 ± 8.7 cm respectively. The prevalence of obesity
(BMI ≥ 27.5 kg/m2) and central obesity (based on waist
circumference) in the study population were 14.8% (n =
46) and 53.7% (n = 167) respectively. The prevalence of
hypertension was 60.2% (n = 186), while metabolic syn-
drome was prevalent in 72.6% (n = 201). A comparison of
socio-demographic, anthropometric and disease prevalence
characteristics of patients with known diabetes and newly
diagnosed diabetes is presented as (Additional file 1: Table S1),
where only mean age and prevalence of hypertension were
significantly different between the two groups.
Prevalence, clinical and biochemical correlates of DR
The prevalence of any degree of DR in the study popula-
tion was 27.4% (n = 76, 95% CI: 22.3 – 33.1). There was no
significant gender difference observed in the prevalence of
Table 2 Prevalence of retinopathy in association with socio-demographic, anthropometric, clinical and biochemical
parameters
Prevalence of diabetic retinopathy % (95% CI)
All adults Males Females
Area of residence
Urban 27.9 (22.7 – 33.6) 36.8 (22.7 – 52.9) 19.6 (10.8 – 31.6)
Rural 26.6 (19.6 – 34.6) 26.9 (17.3 – 38.4) 28.4 (20.5 – 37.6)
Ethnicity
Sinhalese 28.8 (24.1 – 33.9) 33.3 (23.9 – 43.9) 26.2 (19.5 – 33.8)
Tamil 20.0 (6.7 – 41.1) 14.3 (7.1 – 43.0) 25.0 (4.4 – 61.2)
Muslim 21.2 (11.3 – 34.7) 21.4 (5.8 – 47.9) 21.1 (7.1 – 43.3)
Level of education
No formal education 25.0 (8.8 – 49.4) 50.0 (2.5 – 97.5) 20.0 (3.5 – 51.9)
Primary education 49.0 (37.4 – 60.7)§ 50.0 (35.1 – 64.9)§ 48.6 (32.5 – 64.9)§
Secondary education 21.6 (17.1 – 26.6)§ 24.4 (15.8 – 34.8)§ 19.8 (13.6 – 27.5)§
Tertiary education 41.7 (20.4 – 65.6) 45.5 (18.9 – 74.1) 0
Monthly income (LKR)
< 7,000 28.6 (22.4 – 35.4) 40.6 (24.8 – 58.1) 24.8 (17.1 – 33.9)
7,000 – 24,999 28.7 (22.2 – 36.0) 29.6 (18.6 – 42.8) 27.9 (17.7 – 40.1)
25,000 – 49,999 17.6 (6.1 – 36.9) 18.2 (3.2 – 48.3) 16.7 (0.8 – 59.3)
≥ 50,000 0 0 0
Current smoking
Non-smoker 26.5 (24.1 – 28.2)§ 28.4 (23.4 – 33.9)§ 25.6 (19.5 – 32.5)
Smoker 37.5 (32.5 – 42.5)§ 37.5 (32.1 – 42.8)§ 0
Physical activity
Inactive 29.4 (19.8 – 40.7) 36.8 (17.8 – 59.7) 25.0 (12.3 – 42.0)
Moderately active 25.2 (19.0 – 32.3) 26.4 (15.9 – 39.4) 24.2 (14.8 – 35.9)
Active 28.8 (20.9 – 37.8) 33.3 (18.9 – 50.5) 26.9 (17.9 – 37.6)
Central Obesity*
Absent 33.9 (26.0 – 42.4)§ 36.1 (26.8 – 46.6)§ 31.8 (26.5 – 35.8)§
Present 22.0 (15.9 – 29.2)§ 22.7 (15.2 – 33.8)§ 21.7 (17.6 – 26.3)§
Systolic hypertension (> 135 mmHg)
Absent 29.1 (23.4 – 35.3) 33.9 (21.8 – 47.8) 26.5 (18.2 – 36.1)
Present 24.6 (18.4 – 31.7) 25.5 (14.6 – 39.4) 23.9 (14.3 – 35.9)
Diastolic hypertension (> 80 mmHg)
Absent 28.4 (22.6 – 34.8) 31.0 (21.1 – 42.4) 27.1 (20.3 – 34.9)
Present 23.0 (13.7 – 34.7) 28.1 (14.5 – 45.4) 17.2 (6.6 – 34.2)
Hypertension♯
Absent 33.9 (25.6 – 43.1) 37.5 (23.6 – 53.1) 31.9 (21.9 – 43.3)
Present 23.3 (17.3 – 30.2) 26.6 (16.8 – 38.3) 21.2 (14.0 – 30.1)
Peripheral neuropathy
Absent 20.2 (15.7 – 24.7)§ 20.0 (16.5 – 23.5)§ 20.4 (11.2 – 32.6)
Present 30.4 (26.2 – 34.2)§ 34.2 (24.1 – 45.7)§ 28.0 (20.4 – 36.6)
§Values under each variable in a single column with the same superscript are significantly different from each other (p < 0.01); ♯systolic hypertension or diastolic
hypertension or both; *waist circumference > 90 cm for males and > 80 cm for females.
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Table 3 Binary logistic regression analysis in all adults, males and females
Odds ratio (95% CI)
Co-variants All adults Male Female
Duration of diabetes 1.07 (1.01 – 1.14)# 1.06 (0.97 – 1.17) 1.08 (1.00 – 1.16)#
Current smoking 1.67 (1.21 – 2.28)# 1.61 (1.20 – 2.31)# NA
Peripheral neuropathy 1.72 (1.50 – 1.92)* 1.71 (0.78 – 3.75) 1.52 (0.67 – 3.66)
Central obesity 0.55 (0.31 – 0.97)* 0.52 (0.19 – 1.35) 0.59 (0.28 – 1.27)
#p < 0.05; *p < 0.01; NA – Not associated.
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of cataract was 10.9% (Males 9.5%, Females 11.7%; p =
0.52). In the patients with DR, majority had NPDR (93.4%,
n = 71), while only one patient had PDR and 5.3% (n = 4)
had maculopathy. Patients with DR had a significantly lon-
ger duration of diabetes than those without DR (Table 1).
They also had a significantly lower waist circumference,
waist to height ratio and diastolic blood pressure. However,
other socio-demographic, anthropometric, clinical and bio-
chemical parameters were not significantly different in
those with and without DR (Table 1).
In all adults with diabetes the prevalence of DR was
highest in urban residents (p-0.47), Sinhalese (p-0.52)
and those educated up to primary school (Table 2).
Current smokers (37.5%) had a significantly higher preva-
lence of DR than non-smokers (26.5%) (p-0.03). Similarly
patients with diabetic peripheral neuropathy (30.4%) had a
higher prevalence than those without neuropathy (20.2%)
(p-0.006). However, DR was more prevalent in non-obese
(p-0.03) and normotensive adults (p-0.06) (Table 2). No
consistent relationship was observed between DR and
levels of physical activity.
Binary logistic regression analysis
The results of the binary logistic regression analysis in all
adults using the dichotomous variable ‘presence of DR’
as the dependant factor and other independent variables
are shown in Table 3. The overall model was statisticallyTable 4 Prevalence of diabetic retinopathy in South Asian cou
Country Year of study Study
Bangladesh [25] 2013* Popula
India [26] 2005* Popula
India [27] 2005 – 2006 Popula
India [28] 2003 – 2006 Popula
Nepal [29] 2005 – 2006 Hospit
Nepal [30] 2008* Popula
Nepal [31] 2009 Clinic
Pakistan [32] 2006 – 2008 Clinic
Pakistan [33] 2008 – 2009 Popula
Pakistan [34] 2008 – 2010 Clinic
*Year of publication; DR – Diabetic Retinopathy.significant and the Cox & Snell R-Square and Nagelkerke
R Square values were 0.254 and 0.363 respectively. The re-
sults indicate that the duration of diabetes (OR: 1.07),
current smoking (OR: 1.67) and peripheral neuropathy
(OR: 1.72) all were associated with significantly increased
risk of having DR (Table 3). Presence of central obesity
was associated with a reduced risk of having DR (OR:
0.55). However in the two genders only duration of dia-
betes in females and current smoking in men were signifi-
cantly associated with an increase risk of DR (Table 3).
Discussion
To our knowledge, this is first study on the prevalence
of DR in a large nationally representative community
based sample of Sri Lankan adults. Our results show
that the prevalence of DR in Sri Lanka is 27.4% with ma-
jority (93%) having NPDR, while cataract was prevalent
in 10.9% of Sri Lankan adults with diabetes. Two previous
clinic based studies from Sri Lanka in 1993 and 1998
showed a DR prevalence of 31.3% and 15.0% (newly diag-
nosed DM) respectively [12,22]. A more recent (year
2005–2006) clinic based study among adults with young-
onset diabetes (onset < 40 years) demonstrated an overall
DR prevalence of 18.1% [23]. A pooled analysis of 22,896
individuals with diabetes from 35 population-based studies
(1980–2008) around the world showed an overall preva-
lence of 34.6% for any degree of DR [24]. In the same ana-
lysis a sub-group evaluation of South Asians demonstratedntries
setting Prevalence of DR % (number)
tion based (regional) 21.6 (n = 20)
tion based (regional) 17.6 (n = 302)
tion based (regional) 12.2 (n = 342)
tion based (regional) 18.0 (n = 255)
al based 44.7 (n = 166)
tion based (regional) 19.3 (n = 11)
based 20.3 (n = 26)
based 27.4 (n = 460)
tion based (regional) 12.0 (n = 183)
based 25.5 (n = 51)
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of South Asians in the above analysis were residing in
countries outside of South Asia, with only 3 regional stud-
ies from India [24]. In the present study, more than 1/4th
of the Sri Lankan patients with diabetes were found to
have DR, a prevalence that is much higher than what is re-
ported in recent population-based prevalence studies from
individual South Asian countries (Table 4). Although
higher prevalence values are reported in some clinic based
studies, they are likely to be subjected to a significant selec-
tion bias. Differences in socioeconomic factors, including
access to and the level of diabetes care, genetic susceptibil-
ity, racial differences in the effect of DR risk factors are
some of the possible explanations for the observed dispar-
ity in the prevalence rates. Population-based studies in-
corporating host and environmental data are needed to
further clarify the effect of race and ethnicity on DR preva-
lence [24].
Duration of diabetes, current smoking and presence of
diabetes peripheral neuropathy all were significantly as-
sociated with the prevalence of DR in the present study
population. Duration of diabetes is a well known risk
factor for DR and most other complications of diabetes
[24]. The relationship between smoking and DR is contro-
versial, where several studies have shown no relationship
between smoking and long-term incidence, progression of
DR [35,36]. However these findings have been contra-
dicted by other studies [37]. The failure to demonstrate a
clear association between smoking and DR does not imply
that persons with diabetes who smoke should not stop, as
it is a well established vascular factor, associated with
myocardial infarction and death from cardiovascular dis-
ease in patients with diabetes. Diabetic peripheral and
autonomic neuropathy both are well known to be associ-
ated with DR, possible due to the fact that both are medi-
ated by similar aetio-pathogenesis mechanisms [38,39].
Obesity is a well established risk factor for DR, be-
cause of its significant correlation to quality of metabolic
control in patients with diabetes [40]. However, in the
present cohort DR was more prevalent in the non-obese
and patients with DR had a significantly lower waist cir-
cumference. It is possible that patients with DR in the
present cohort had poor glycaemic control with result-
ant loss of weight and rapid progression of the retinop-
athy, resulting in DR being more prevalent in those
without obesity. A similar result was observed in a small
clinic based study of patients with Type-2 diabetes from
Vanuatu islands, where patients with DR had a signifi-
cantly lower BMI than those without [41]. Furthermore,
although statistically not significant Fasting Blood Glu-
cose values were higher in patients with DR than those
without, however we lack HbA1c data to extrapolate on
long term glycaemic control. Hypertension is another
well known risk factor for DR [42]. However in thepresent cohort we did not observe a significant relation-
ship between hypertension and prevalence of DR. In fact,
DR was more prevalent in the normotensive diabetic
population, although this difference was not statistically
significant. In the present population with diabetes,
nearly 2/3rd of the patients were hypertensive, making it
likely that a high number of patients with and without
DR were hypertensive irrespective of DR status.
There are several limitations to our study; the cross
sectional design limits the inference of causality and can
only demonstrates an association between DR and iden-
tified risk factors. Hence, prospective follow up studies
among South Asian adults with uncomplicated diabetes
is required to identify risk factors for DR during subse-
quent follow up. The lack of fundus photographs is also
a limitation, since retinal photography is the gold stand-
ard for the diagnosis of DR; it is possible that we may
have missed patients with early DR, hence underestimat-
ing the prevalence. However, in resource limited settings
such as in Sri Lanka, ophthalmoscopy by experienced
ophthalmologists also has been shown to have accept-
able sensitivity [43]. In addition the grading given by the
ophthalmologist was not validated by measuring intra/
inter-observer concordance. In addition since the pa-
tients with newly diagnosed diabetes were not referred
for eye examination, it could have been a source of se-
lection bias and the prevalence of DR may have been
overestimated. We were also unable to evaluate data on
treatment, including insulin therapy, glycaemic control
and their associations with DR. Furthermore, we did not
have complete data for the prevalence of nephropathy to
evaluate its association with DR.
Conclusions
Our results demonstrate that nearly 1/3rd of Sri Lankan
adults with self-reported diabetes are having retinopathy.
Diabetic retinopathy was associated with duration of dia-
betes, cigarette smoking and peripheral neuropathy.
However, further prospective follow up studies among
South Asian adults are required to establish causality for
the risk factors identified.
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